Biocryst Pharmaceuticals (BCRX) EPS (Basic) (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) reported EPS (Basic) of -$2.98 for Q1 2026, down 1945313.62% on a YoY basis from N/an in Q1 2025, and down 354.7% quarter-over-quarter from $1.17 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) EPS (Basic) (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals has reported EPS (Basic) for 17 years, with the latest figure at -$2.98 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 1945313.62% year-over-year to -$2.98; the trailing twelve-month figure through Mar 2026 stood at -$1.73 (down 565.38% YoY), and the FY2025 full-year result was $1.26, up 393.02% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$2.98, down from $1.17 in the prior quarter.
- The five-year high for EPS (Basic) was $1.17 in Q4 2025, with the low at -$2.98 in Q1 2026.
- Historically, EPS (Basic) has averaged -$0.27 across 5 years, with a median of -$0.19 in 2023.
- Annual changes were most pronounced in 2025 — EPS (Basic) jumped 1000.0% — and 2026, when it sank 1945313.62%.
- Biocryst Pharmaceuticals' EPS (Basic) stood at -$0.38 in 2022, then advanced by 18.42% to -$0.31 in 2023, then soared by 58.06% to -$0.13 in 2024, then soared by 1000.0% to $1.17 in 2025, then sank by 354.7% to -$2.98 in 2026.
- The last three EPS (Basic) figures came in at -$2.98 (Q1 2026), $1.17 (Q4 2025), and $0.06 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.32 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.32 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.97 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.83 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Biocryst Pharmaceuticals | 2.04 Bn | 1.81 Bn | 151.04 Mn | -2.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.98 |
| Dec 31, 2025 | 1.17 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.13 |
| Sep 30, 2024 | -0.07 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.31 |
| Sep 30, 2023 | -0.19 |
| Jun 30, 2023 | -0.40 |
| Mar 31, 2023 | -0.28 |
| Dec 31, 2022 | -0.38 |
| Sep 30, 2022 | -0.23 |
| Jun 30, 2022 | -0.32 |
| Mar 31, 2022 | -0.40 |
| Dec 31, 2021 | -0.10 |
| Sep 30, 2021 | -0.33 |
| Jun 30, 2021 | -0.24 |